Fundraising Fox

Olema Pharmaceuticals

NASDAQ: OLMA

San Francisco, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

CL
Cyrus L. Harmon, Ph.D.Co-founder
CH
Cyrus HarmonCo-founder
DC
David C. Myles, Ph.D.Executive
SB
Sean Bohen, M.D., Ph.D.Executive
NZ
Naseem Zojwalla, M.D.Executive
SK
Shane KovacsExecutive
DM
David MylesNamed on SEC filing
MB
Marina BozilenkoNamed on SEC filing
PK
Peter KusherNamed on SEC filing
FM
Frank McCormickNamed on SEC filing
LF
Lawrence FritzNamed on SEC filing
GH
Gorjan HrustanovicNamed on SEC filing

Investors · 1

Foresite CapitalWest Hollywood

Reported raises · per SEC filings

Form D private placements

$527.4M disclosed across 5 rounds · 2018–2024

▶$250MraisedDec 2024 · 26 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David C. Myles, Ph.D.Executive Officer
  • Sandra Horning, M.D.Director
  • Scott GarlandDirector
  • Sean Bohen, M.D., Ph.D.Executive Officer, Director
  • Andrew RappaportDirector
  • Graham Walmsley, M.D., Ph.D.Director
  • Naseem Zojwalla, M.D.Executive Officer
  • Yi LarsonDirector
  • Cyrus L. Harmon, Ph.D.Director
  • Shane KovacsExecutive Officer
  • Ian ClarkDirector
  • Gorjan Hrustanovic, Ph.D.Director
  • Cynthia ButittaDirector
Offering amount
$250M
Amount sold
$250M
Sales commissions
$12.5M
Placement agents
Goldman Sachs & Co. LLC, LifeSci Capital LLC, Oppenheimer & Co. Inc., H.C. Wainright & Co., LLChow, Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Jefferies LLC
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$130MraisedSep 2023 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Yi LarsonDirector
  • Shane KovacsExecutive Officer
  • Cyrus L. Harmon, Ph.D.Director
  • Ian ClarkDirector
  • Graham Walmsley, M.D., Ph.D.Director
  • Sandra Horning, M.D.Director
  • David C. Myles, Ph.D.Executive Officer
  • Andrew RappaportDirector
  • Gorjan Hrustanovic, Ph.D.Director
  • Naseem Zojwalla, M.D.Executive Officer
  • Sean Bohen, M.D., Ph.D.Executive Officer, Director
  • Cynthia ButittaDirector
Offering amount
$130M
Amount sold
$130M
First sale
Sep 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$87.4MraisedOct 2020 · 27 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter KushnerExecutive Officer
  • Kinney HornExecutive Officer
  • David MylesExecutive Officer
  • Shane KovacsExecutive Officer
  • Graham WalmsleyDirector
  • Andrew RappaportDirector
  • Frank McCormickDirector
  • Gorjan HrustanovicDirector
  • Cyrus HarmonExecutive Officer, Director
  • Ian ClarkDirector
  • Cynthia ButittaDirector
  • Sean BohenExecutive Officer, Director
  • John MoriartyExecutive Officer
Offering amount
$87.4M
Amount sold
$87.4M
Sales commissions
$1.4M
Placement agents
Cowen and Company, LLC
First sale
Sep 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$53.9MraisedJun 2020 · 16 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Pamela KleinExecutive Officer
  • Gorjan HrustanovicDirector
  • Andrew RappaportDirector
  • Graham WalmsleyDirector
  • Cyrus HarmonExecutive Officer, Director
  • Frank McCormickDirector
  • Peter KushnerExecutive Officer
Offering amount
$55.4M
Amount sold
$53.9M
First sale
Mar 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.1MraisedAug 2018 · 13 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew RappaportDirector
  • David MylesExecutive Officer
  • Marina BozilenkoDirector
  • Peter KusherExecutive Officer, Director
  • Frank McCormickDirector
  • Cyrus HarmonExecutive Officer, Director
  • Lawrence FritzDirector
  • Gorjan HrustanovicDirector
  • Andrei ManoliuDirector
Offering amount
$6.1M
Amount sold
$6.1M
First sale
Jul 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Olema Pharmaceuticals posts higher loss with strong cash | OLMA Quarterly Report (10-Q)stocktitan.net · Aug 2026OLMA Stock | Olema Pharmaceuticals, Inc. Price, Quote, News & Analysis - TipRanks.comtipranks.com · Apr 2026Goldman Sachs Raises Stake in Olema Pharmaceuticals, Inc. (OLMA)finance.yahoo.com · Sep 2025

Frequently asked questions

Who founded Olema Pharmaceuticals?
Olema Pharmaceuticals was founded by Cyrus L. Harmon, Ph.D., Cyrus Harmon.
Who are Olema Pharmaceuticals's investors?
Olema Pharmaceuticals's investors include Foresite Capital.
How much funding has Olema Pharmaceuticals raised?
Olema Pharmaceuticals has disclosed $527.4M raised across 5 rounds.
Where is Olema Pharmaceuticals headquartered?
Olema Pharmaceuticals is headquartered in San Francisco, US.